The FDA is set to decide Friday on a gene editing technique for patients with sickle cell disease. It would be the first use of CRISPR in the United States to treat a disease. CBS News' chief medical correspondent Dr. Jon LaPook has more.
#news #health #sicklecelldisease
Each weekday morning, "CBS Mornings” co-hosts Gayle King, Tony Dokoupil and Nate Burleson bring you the latest breaking news, smart conversation and in-depth feature reporting. "CBS Mornings" airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app.
Subscribe to “CBS Mornings” on YouTube: [ Ссылка ]
Watch CBS News: [ Ссылка ]
Download the CBS News app: [ Ссылка ]
Follow "CBS Mornings" on Instagram: [ Ссылка ]
Like "CBS Mornings" on Facebook: [ Ссылка ]
Follow "CBS Mornings" on Twitter: [ Ссылка ]
Subscribe to our newsletter: [ Ссылка ]
Try Paramount+ free: [ Ссылка ]
For video licensing inquiries, contact: licensing@veritone.com
